$10.46
0.32[3.16%]
At close: Apr 23
$10.46
0[0.00%]
After Hours: 9:22AM EDT
INmune Bio
(NASDAQ:INMB)INmune Bio Stock (NASDAQ:INMB), Earnings Estimates, EPS, and Revenue
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.580
Quarterly Revenue Estimate
$40K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$155K
Analyze the earnings history of INmune Bio using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | PM | INMB | Q1 | -$0.36 | -$0.58 | — | — | $38.00K | $40.00K | — | — | Get Alert |
| 03/28/2024 | PM | INMB | Q4 | -$0.32 | -$0.44 | -$0.47 | -6.82% | $97.00K | $40.00K | $28.00K | -30.00% | Get Alert |
| 11/01/2023 | PM | INMB | Q3 | -$0.43 | -$0.41 | -$0.48 | -17.07% | $98.00K | — | $43.00K | — | Get Alert |
| 08/07/2023 | PM | INMB | Q2 | -$0.38 | -$0.40 | -$0.36 | 10.00% | $16.00K | — | $46.00K | — | Get Alert |
| 05/03/2023 | PM | INMB | Q1 | -$0.39 | -$0.02 | -$0.36 | -1700.00% | $163.00K | — | $38.00K | — | Get Alert |
| 03/02/2023 | PM | INMB | Q4 | -$0.55 | -$0.48 | -$0.32 | 33.33% | $163.00K | — | $97.00K | — | Get Alert |
| 11/02/2022 | PM | INMB | Q3 | -$0.55 | -$0.52 | -$0.43 | 17.31% | $14.00K | — | $98.00K | — | Get Alert |
| 08/03/2022 | PM | INMB | Q2 | -$0.44 | -$0.50 | -$0.38 | 24.00% | $0.00 | — | $16.00K | — | Get Alert |
| 05/05/2022 | PM | INMB | Q1 | -$0.32 | -$0.64 | -$0.39 | 39.06% | $4.00K | — | $163.00K | — | Get Alert |
| 03/03/2022 | PM | INMB | Q4 | -$0.24 | -$0.58 | -$0.55 | 5.17% | $10.92K | — | $163.00K | — | Get Alert |
| 11/03/2021 | PM | INMB | Q3 | -$0.36 | -$0.38 | -$0.55 | -44.74% | $0.00 | $970.00K | $14.00K | -98.56% | Get Alert |
| 08/04/2021 | PM | INMB | Q2 | -$0.20 | -$0.34 | -$0.44 | -29.41% | $0.00 | — | $0.00 | — | Get Alert |
| 05/05/2021 | PM | INMB | Q1 | -$0.19 | -$0.27 | -$0.32 | -18.52% | $0.00 | — | $4.00K | — | Get Alert |
| 03/04/2021 | PM | INMB | Q4 | -$0.22 | — | -$0.24 | — | $0.00 | — | $10.92K | — | Get Alert |
| 11/05/2020 | PM | INMB | Q3 | -$0.28 | -$0.17 | -$0.36 | -111.76% | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2020 | PM | INMB | Q2 | -$0.04 | -$0.20 | -$0.20 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 05/14/2020 | PM | INMB | Q1 | -$0.20 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | Get Alert |
| 03/11/2020 | AM | INMB | Q4 | — | -$0.25 | -$0.22 | 12.00% | — | — | $0.00 | — | Get Alert |
| 11/08/2019 | PM | INMB | Q3 | -$0.18 | -$0.19 | -$0.28 | -47.37% | — | — | $0.00 | — | Get Alert |
FAQ
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio (INMB) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?
The Actual EPS was $-0.47, which missed the estimate of $-0.44.
What were INmune Bio’s (NASDAQ:INMB) revenues?
The Actual Revenue was $28K, which missed the estimate of $40K.
Browse earnings estimates, EPS, and revenue on all stocks.